Franklin Resources’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-31,180
| Closed | -$2.25M | – | 3282 |
|
|
2025
Q4 | $2.25M | Sell |
31,180
-1,400
| -4% | -$90.4K | ﹤0.01% | 1728 |
|
|
2025
Q3 | $1.42M | Sell |
32,580
-4,850
| -13% | -$196K | ﹤0.01% | 1926 |
|
|
2025
Q2 | $1.06M | Sell |
37,430
-29,465
| -44% | -$878K | ﹤0.01% | 1967 |
|
|
2025
Q1 | $1.97M | Buy |
66,895
+3,496
| +6% | +$109K | ﹤0.01% | 1696 |
|
|
2024
Q4 | $1.84M | Sell |
63,399
-9,648
| -13% | -$403K | ﹤0.01% | 1760 |
|
|
2024
Q3 | $3.41M | Buy |
73,047
+50,908
| +230% | +$2.21M | ﹤0.01% | 1522 |
|
|
2024
Q2 | $904K | Buy |
+22,139
| New | +$635K | ﹤0.01% | 1965 |
|
|
2023
Q4 | – | Sell |
-344,328
| Closed | -$2.2M | – | 2704 |
|
|
2023
Q3 | $2.2M | Buy |
344,328
+114
| +0% | +$982 | ﹤0.01% | 1359 |
|
|
2023
Q2 | $3.82M | Sell |
344,214
-185,515
| -35% | -$2.33M | ﹤0.01% | 1192 |
|
|
2023
Q1 | $8.13M | Buy |
529,729
+179,666
| +51% | +$3.95M | ﹤0.01% | 975 |
|
|
2022
Q4 | $7.77M | Buy |
+350,063
| New | +$5.22M | ﹤0.01% | 1009 |
|
|
2020
Q3 | – | Sell |
-300,000
| Closed | -$7.11M | – | 1894 |
|
|
2020
Q2 | $7.11M | Buy |
+300,000
| New | +$8.65M | ﹤0.01% | 943 |
|
Other funds holding RNAM
Franklin Resources's RNAM Position: Q1 2026 in Review
Franklin Resources sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 31,180 shares — an estimated $2.25M sold.
Franklin Resources first reported a position in RNAM in Q2 2020 and held it in 12 quarters. The position peaked at $8.13M in Q1 2023. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- Franklin Resources reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- Franklin Resources sold 31,180 Avidity Biosciences shares in Q1 2026, an estimated $2.25M.
- Franklin Resources first reported a position in Avidity Biosciences in Q2 2020 and held it in 12 quarters.
- Franklin Resources's Avidity Biosciences position peaked at $8.13M in Q1 2023.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.